Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: A multicentre, randomised, phase lll study.

Trial Profile

Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: A multicentre, randomised, phase lll study.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Porfimer sodium (Primary)
  • Indications Biliary cancer; Gallbladder cancer
  • Focus Therapeutic Use
  • Acronyms PHOTOSTENT-02
  • Sponsors Alcon
  • Most Recent Events

    • 19 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jul 2011 New source added and integrated (European Clinical Trials Database, EudraCT2005-001173-96).
    • 21 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top